Global Biochip Market-Technologies, Market Share and Industry Forecast to 2024

  • ID: 4027582
  • Report
  • Region: Global
  • 240 Pages
  • Occams Business Research and Consulting
UP TO OFF
until Mar 31st 2019
1 of 5
The Global Biochips Market is Anticipated to Grow at a CAGR of 18.4 %

FEATURED COMPANIES

  • Affymetrix Inc
  • Biochain Institute Inc
  • Bio-Rad Laboratories Inc
  • Cepheid Inc
  • EMD Millipore
  • Gamida For Life Group
  • MORE

The global biochips market is anticipated to grow at a CAGR of 18.4 % during 2017 to 2024. The market has generated the revenue $7.63 Billion in 2016 and is anticipated to reach up to $17.65 Billion by 2022. The major driving forces for the market of biochips are Rise in diagnosis & treatment of cancer, Increase Government funding, Growth in personalized medicine and Technical advances.

In today’s world the eczema and food allergies become the most common chronic non-communicable diseases in children in several courtesies. It is seen that more than 8% population are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy Due to the increase in number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes increased the demand of diagnosis globally which increased the market of biochip worldwide.

According to the World Health Organization, in 2015, it has seen that in the U.S. more than 1,658,370 new cancer cases had come in which more than 848,200 male cancer cases are there and 810,170 female cancer cases.

The global biochips market is segmented on the basis of applications and types. In applications the market is segmented by lab-on-chip (LOC) market, DNA micro array market and protein micro array. Based on types the market is segmented into protein microarray market and other array market DNA microarrays held the largest share segment of biochips market and is expected to holds the largest contributor during 2017-2024, followed by lab-on-chip owing to its wide applications and increased adoption by various segments such as pharmaceutical, biotechnology, companies, and research laboratories and the protein microarrays will be the third largest due to advances in the fields of proteomics and genomics.

Geographically the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America dominates the global biochips market owing to large number of aging population and broad technical applications of biochips followed by Europe and Asia-Pacific. Asia-Pacific market will drive the growth of the market in future owing to growing economies like India and China.

Some of the major players of the market are Thermofisher, Agilent technologies Inc, Biochain institute Inc, Biomérieux sa, Bio-rad laboratories Inc, Caliper life sciences in, Cepheid In, Cybrdi Inc. Emd Millipore, Fluidigm corp, Gamida for life group, Illumina Inc, Imgenex, Life technologies corp, Origene technologies Inc. Acquisition, merger, innovation and new product launch are the major technologies which helps to sustain in the market.

In 2016, Thermofisher, the U.S. based company has announced that they had completed the acquisition of Affymetrix Inc., the U.S. based company that provides cellular and genetic analytics products.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Affymetrix Inc
  • Biochain Institute Inc
  • Bio-Rad Laboratories Inc
  • Cepheid Inc
  • EMD Millipore
  • Gamida For Life Group
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Market Scope

2. Market Overview
2.1. Global Biochips Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360 Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Market Share Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Rise In Diagnosis & Treatment Of Cancer
3.1.2. Increase Government Funding
3.1.3. Growth In Personalized Medicine
3.1.4. Technical Advances
3.2. Market Restraints
3.2.1. Lack Of Healthcare Coverage Restricts The Adoption
3.2.2. Knowledge Constraints With Respect To Technical Know-How
3.3. Market Opportunities
3.3.1. Growth Of Market In The Sub-Continent Of Asia
3.3.2. Widening Applications Market
3.4. Market Challenges
3.4.1. Complexity Of Biological Systems
3.4.2. Unclear Regulatory Guidelines
3.4.3. High Instrumentation Costs

4. Market Segmentation
4.1. Global Biochips Market By Type 2015-2024($ Million)
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Dna Chips 2015-2024($ Million)
4.1.5.1.1. Market Applications
4.1.5.1.1.1. Agricultural Biotechnology
4.1.5.1.1.2. Cancer Diagnosis And Treatment
4.1.5.1.1.3. Drug Discovery
4.1.5.1.1.4. Gene Expression
4.1.5.1.1.5. Genomics
4.1.5.1.1.6. Single Nucleotide Polymorphism (SNP) Genotyping
4.1.5.1.1.7. Others
4.1.5.1.2. Adoption Scenario & Market Determinants
4.1.5.1.3. Market Estimations And Forecast 2015-2024($ Million)
4.1.5.1.4. Key Conclusions
4.1.5.2. Lab-On-A-Chip 2015-2024($ Million)
4.1.5.2.1. Market Applications
4.1.5.2.1.1. Clinical Diagnostics
4.1.5.2.1.2. Drug Discovery
4.1.5.2.1.3. Genomics
4.1.5.2.1.4. In Vitro Diagnosis (IVD) & Point-Of-Care (POC)
4.1.5.2.1.5. Proteomics
4.1.5.2.1.6. Others
4.1.5.2.2. Adoption Scenario & Market Determinants
4.1.5.2.3. Market Estimations And Forecast 2015-2024($ Million)
4.1.5.2.4. Key Conclusions
4.1.5.3. Protien Chips 2015-2024($ Million)
4.1.5.3.1. Market Applications
4.1.5.3.1.1. Diagnostics
4.1.5.3.1.2. Drug Discovery
4.1.5.3.1.3. Expression Profiling
4.1.5.3.1.4. High Throughput Screening (HTS)
4.1.5.3.1.5. Proteomics
4.1.5.3.1.6. Others
4.1.5.3.2. Adoption Scenario & Market Determinants
4.1.5.3.3. Market Estimations And Forecast 2015-2024($ Million)
4.1.5.3.4. Key Conclusions
4.1.5.4. Others 2015-2024($ Million)
4.1.5.4.1. Market Applications
4.1.5.4.1.1. Cell Arrays
4.1.5.4.1.2. Tissue Arrays
4.1.5.4.2. Adoption Scenario & Market Determinants
4.1.5.4.3. Market Estimations And Forecast 2015-2024($ Million)
4.1.5.4.4. Key Conclusions
4.2. Global Biochips Market By End User 2015-2024($ Million)
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Biotechnology And Pharmaceutical Companies 2015-2024($ Million)
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecast 2015-2024($ Million)
4.2.5.1.3. Key Conclusions
4.2.5.2. Hospitals And Diagnostics Centers 2015-2024($ Million)
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecast 2015-2024($ Million)
4.2.5.2.3. Key Conclusions
4.2.5.3. Academic & Research Institutes 2015-2024($ Million)
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecast 2015-2024($ Million)
4.2.5.3.3. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List Of M&A
5.1.2. List Of JV
5.1.3. List Of Product Launches
5.1.4. List Of Partnership

6. Global Biochips Market By Region (Revenue Analysis) 2015-2024($ Million)
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Geographic Segmentation
6.4.1. North America
6.4.1.1. Industry Application Analysis
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.1.2.1.2. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.1.2.2.2. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Application Analysis
6.4.2.2. Top Country Analysis
6.4.2.2.1. UK
6.4.2.2.1.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.1.2. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.2.2. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.3.2. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.4.2. Key Conclusions
6.4.2.2.5. Italy
6.4.2.2.5.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.5.2. Key Conclusions
6.4.2.2.6. Rest Of Europe
6.4.2.2.6.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.2.2.6.2. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Application Analysis
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.1.2. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.2.2. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.3.2. Key Conclusions
6.4.3.2.4. South Korea
6.4.3.2.4.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.4.2. Key Conclusions
6.4.3.2.5. Australia
6.4.3.2.5.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.5.2. Key Conclusions
6.4.3.2.6. Rest Of Asia Pacific
6.4.3.2.6.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.3.2.6.2. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Application Analysis
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.4.2.1.2. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecast 2015-2024($ Million)
6.4.4.2.2.2. Key Conclusions

7. Company Profiles
7.1. Affymetrix Inc
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.2. Agilent Technologies Inc
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.3. Biochain Institute Inc
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.4. Biomérieux SA
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.5. Bio-Rad Laboratories Inc
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.6. Caliper Life Sciences In
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.7. Cepheid Inc
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.8. Cybrdi Inc
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.9. EMD Millipore
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.10. Fluidigm Corp
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.11. Gamida For Life Group
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.12. Illumina Inc
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.13. Imgenex
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.14. Life Technologies Corp
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.15. Origene Technologies Inc
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis

List Of Tables

1. Global Biochips Market By Type 2015-2024($ Million)
2. Global DNA Chips Market By Geography 2015-2024($ Million)
3. Global Lab On A Chip Market By Geography 2015-2024($ Million)
4. Global Protien Chips Market By Geography 2015-2024($ Million)
5. Global Other Chips Market By Geography 2015-2024($ Million)
6. Global Biochip Market By End User 2015-2024($ Million)
7. Global Biotechnology And Pharmaceutical Companies By Geography 2015-2024($ Million)
8. Global Hospitals And Diagnostics Centers Market By Geography 2015-2024($ Million)
9. Global Academic & Research Institutes Market By Geography 2015-2024($ Million)
10. Global Others Market By Geography 2015-2024($ Million)
11. North America Biochips Market 2015-2024($ Million)
12. Europe Biochips Market 2015-2024($ Million)
13. Asia Pacific Biochips Market 2015-2024($ Million)
14. Rest Of The World Biochips Market 2015-2024($ Million)

List Of Figures
1. Global Dna Chips Market 2015-2024($ Million)
2. Global Lab On A Chip Market 2015-2024($ Million)
3. Global Protien Chips Market 2015-2024($ Million)
4. Global Other Chips Market 2015-2024($ Million)
5. Global Biotechnology And Pharmaceutical Companies Market 2015-2024($ Million)
6. Global Hospitals And Diagnostics Centers Market 2015-2024($ Million)
7. Global Academic & Research Institutes Market 2015-2024($ Million)
8. United States (U.S.) Biochips Market 2015-2024($ Million)
9. Canada Biochips Market 2015-2024($ Million)
10. United Kingdom (UK) Biochips Market 2015-2024($ Million)
11. France Biochips Market 2015-2024($ Million)
12. Germany Biochips Market 2015-2024($ Million)
13. Spain Biochips Market 2015-2024($ Million)
14. Italy Biochips Market 2015-2024($ Million)
15. Roe Biochips Market 2015-2024($ Million)
16. India Biochips Market 2015-2024($ Million)
17. China Biochips Market 2015-2024($ Million)
18. Japan Biochips Market 2015-2024($ Million)
19. Korea Biochips Market 2015-2024($ Million)
20. Australia Biochips Market 2015-2024($ Million)
21. Roapac Biochips Market 2015-2024($ Million)
22. Latin America Biochips Market 2015-2024($ Million)
23. Mena Biochips Market 2015-2024($ Million)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Affymetrix Inc
  • Biochain Institute Inc
  • Bio-Rad Laboratories Inc
  • Cepheid Inc
  • EMD Millipore
  • Gamida For Life Group
  • MORE

Global Biochips market is anticipated to grow at the CAGR of 18.4% during 2017-2024

The global biochip market has generated the revenue $7.63 Billion in 2017 and is anticipated to reach up to $17.65 Billion by 2024. The Increase Government funding in medical sector helped to boost the market of biochips. For example, in India according to new health protection scheme the government will provide health cover up to one lakh rupees per family.

Rise in diagnosis & treatment of cancer: growth Drivers

The cancer cases have become one of the major concern for the globe, it was estimated that in 2015, approx. 15.1 million new cancer cases diagnosed worldwide in which more than half of these cases are from economically developing countries. In 2015, it has estimated that approx. 8.9 death caused because of cancer and is predicted to reach up to 13 million in 2030, worldwide.

Further, owing to the rising cancer cases in developed region such as US, Canada has increased the demand of biochips. According to world health organization in 2015 it has seen that in U.S. more than 1658370 new cancer cases had come in which more than 848200 male cancer cases are there and 810170 female cancer cases. It has also seen that more than 589430 death has caused due to cancer in which more than 312150 are male and 277280 are female.

Similarly, in developing countries such as India it has seen that in 2015 more than 666,563 death has caused due to cancer in which 305,000 are females and 361,474 are male. Due to increasing cancer cases increased the demand of diagnosis worldwide which automatically accelerated the market of biochips. 

Increasing aging population: growth opportunity

The increasing aging population worldwide also become the major factor which increase the market of biochips globally. It has seen that in north America more than 15 percent of the total population are above the age 65 in which US holds more than 15 percent of the total population and Canada holds 15 percent of the total population age 65 and above.

Due to increasing aging population worldwide become one of the key factor which increased the demand of diagnosis helps to accelerated the market of biochips devices.

North America: Dominating region

North America holds the largest share of the biochips market in 2015. The large share of this regional segment can majorly be credited to the increasing geriatric population, rising prevalence of lifestyle diseases, such as cardiac disorders, asthma, diabetes, rising adoption of biochips and a noteworthy number of ongoing research activities and discoveries related to biochips in the North American region.

Note: Product cover images may vary from those shown
5 of 5
  • Affymetrix Inc
  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • Biochain Institute Inc
  • Biomérieux SA
  • Caliper Life Sciences In
  • Cepheid Inc
  • Cybrdi Inc
  • EMD Millipore
  • Fluidigm Corp
  • Gamida For Life Group
  • Illumina Inc
  • IMGE
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll